Pharmacy and Medicines benchmark values
Some Pharmacy and Medicine metrics have benchmark values rather than using the national median for comparison.
See the separate article on top 10 medicines additional savings targets.
Top 10 Medicines – Additional Savings Delivered to Current Month
This metric, which totals up the additional savings delivered for all top 10 medicines, has a trust-specific target based on each trust’s spending and prescribing activity last year.
This metric displays a red-amber-green (RAG) rating rather than dividing into quartiles, because there are specific range targets.
| Range of values | Red-amber-green (RAG) rating |
|---|---|
| Less than 80% | Red |
| 80 to 100% | Amber |
| Greater than 100% | Green |
Biosimilar Medicine Uptake (Monthly)
These top 10 medicines metrics measure how much the trust is using a biosimilar version of a medicine rather than the costlier originator version. They are red-green rated depending on whether the trust has met the uptake target. Each of the biosimilar medicines has 80% uptake target and non-biosimilar medicines have different targets.
For example, for Infliximab:
| Range of values | Red-green rating |
|---|---|
| Less than 90% | Red |
| Greater than 90% | Green |
ePrescribing benchmarks
These metrics are linked to the NHS Digital maturity roadmap assessment and represent the percentage of total prescribing delivered through an electronic prescribing system, across 4 areas. This metric is also red-amber-green rated.
The upper benchmark is 75% and lower benchmark is 25%.
| Range of values | Red-amber-green (RAG) rating |
|---|---|
| Less than 25% | Red |
| 25 to 75% | Amber |
| Greater than 75% | Green |